Webinars

Introduction to liquid biopsies for precision oncology: Current status of oncology biomarker testing needs from the clinical perspective

Presented at: Now on demand! OncomineWorld 2025: A virtual NGS education meeting

Sponsored by: Thermo Fisher Scientific

Speaker

Simon Heeke, PhD

Head of Liquid Biopsy Translational Group, Assistant Professor, Thoracic Head and Neck Oncology, MD Anderson Cancer Center, Houston, Texas, USA
BIOGRAPHY

Abstract

The presentation "Introduction to Liquid Biopsies for Precision Oncology" by Simon Heeke, PhD, provides an overview of the use of liquid biopsies in cancer treatment and monitoring. It highlights the advantages of liquid biopsies over traditional tissue biopsies, such as being minimally invasive and offering real-time insights into tumor biology through various samples like blood plasma. The presentation discusses the detection of actionable mutations using circulating tumor DNA (ctDNA) and RNA (ctRNA), and the correlation of liquid biopsy results with treatment response and resistance. Additionally, it addresses the expanded access and rapid turnaround times that liquid biopsies offer, as well as their application beyond blood samples, including cerebrospinal fluid and fine needle aspiration supernatants

Learning Objectives

Gain a deeper understanding of the diverse applications of next-generation sequencing (NGS) in clinical oncology research
Explore the latest important biomarkers in clinical oncology research, such as HRD and
Uncover the remarkable ease, simplicity, and speed at which NGS can revolutionize your work, while acquiring valuable tools to explore its vast possibilities

Webinars will be available for unlimited on-demand viewing after live event.

Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.